|
TANIAI Makiko
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Position Associate Professor |
|
| Article types | Original article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Impact of continued administration of tolvaptan on cirrhotic patients with ascites. |
| Journal | Formal name：BMC pharmacology & toxicology Abbreviation：BMC Pharmacol Toxicol ISSN code：(2050-6511)2050-6511(Linking) |
| Domestic / Foregin | Foregin |
| Volume, Issue, Page | 19(1),pp.87 |
| Author and coauthor | KOGISO Tomomi,SAGAWA Takaomi,KODAMA Kazuhisa,TANIAI Makiko,TOKUSHIGE Katsutoshi |
| Publication date | 2018/12 |
| Summary | Long-term tolvaptan treatment increased serum levels of albumin, decreased ammonia levels, and preserved renal function after 1 year of treatment. A reduction in body weight after 1 week was associated with a favorable outcome of tolvaptan therapy. |
| DOI | 10.1186/s40360-018-0277-3 |
| PMID | 30563565 |